Satiety hormone may decrease risk of Alzheimer's disease

31 Jan 2019


Research, published in Neurobiology of Aging, suggests that individuals with high levels of the satiety hormone, cholecystokinin, may have a lower risk of developing Alzheimer's disease.

Science Daily


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story